Psyence Biomedical Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PARALLEL ADVISORS, LLC | 08/05/2026 | 151.25 K | $574.75 K | 0.00% | 10.21% |
| ADVISORSHARES INVESTMENTS LLC | 08/11/2026 | 122.18 K | $373.88 K | 100.00% | 8.25% |
| MORGAN STANLEY | 08/13/2026 | 37.80 K | $115.68 K | 100.00% | 2.55% |
| JANE STREET GROUP, LLC | 08/14/2026 | 30.43 K | $93.12 K | 100.00% | 2.05% |
| XTX TOPCO LTD | 08/14/2026 | 15.09 K | $46.19 K | 100.00% | 1.02% |
| CITADEL ADVISORS LLC | 09/02/2026 | 11.69 K | $35.78 K | 100.00% | 0.79% |
| STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD | 08/17/2026 | 89 | $272 | 0.00% | 0.01% |
| UBS GROUP AG | 08/13/2026 | 60 | $184 | 100.00% | 0.00% |
| CAITLIN JOHN, LLC | 08/17/2026 | 35 | $107 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Psyence Biomedical Ltd. institutional Ownership - FAQ's
During the previous two years, 9 institutional investors and hedge funds held shares of Psyence Biomedical Ltd.. The most heavily invested institutionals were:
Parallel Advisors, LLC: 151,250
AdvisorShares Investments LLC: 122,184
MORGAN STANLEY: 37,804
JANE STREET GROUP, LLC: 30,431
XTX Topco Ltd: 15,094
CITADEL ADVISORS LLC: 11,693
24.88% of Psyence Biomedical Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 368.64 K shares in the last 24 months. This purchase volume represents approximately $940.03 K in transactions.